Vaxcyte, Inc. (PCVX) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$923.67M | -62.2% |
| 2024 | -$569.55M | -21.7% |
| 2023 | -$468.04M | -101.5% |
| 2022 | -$232.26M | -124.0% |
| 2021 | -$103.67M | -15.7% |
| 2020 | -$89.58M | -65.4% |
| 2019 | -$54.15M | -52.4% |
| 2018 | -$35.53M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$923.67M | -62.2% |
| 2024 | -$569.55M | -21.7% |
| 2023 | -$468.04M | -101.5% |
| 2022 | -$232.26M | -124.0% |
| 2021 | -$103.67M | -15.7% |
| 2020 | -$89.58M | -65.4% |
| 2019 | -$54.15M | -52.4% |
| 2018 | -$35.53M | — |